HIDRADENITIS SUPPURATIVA (HS)

This study is testing whether secukinumab, an injectable medication, can reduce symptoms of moderate to severe hidradenitis suppurativa (HS) in Chinese adults. HS is a chronic, painful skin condition that causes lumps and sores. The study will follow 36 participants for about a y…

This study is testing a new method for treating a painful skin condition called Hidradenitis Suppurativa (HS). Researchers want to see if injecting an approved medication directly into the skin lesions works better and causes fewer side effects than the standard injection under t…

This study is testing whether a targeted course of radiation therapy can provide lasting relief for people with moderate to severe hidradenitis suppurativa (HS) that hasn't responded well to other treatments. Ten adult participants with HS in both armpits will receive radiation t…

This study aims to see if one type of laser treatment works as well as another for managing hidradenitis suppurativa (HS), a chronic skin condition. It will enroll 21 participants who have HS but are not on other strong medications. Researchers will compare how well each laser re…

This study is testing an investigational drug called SCT650C for adults with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition that causes painful lumps. The main goal is to see if the drug can safely reduce the number of painful abscesses and nodules by …

This study aims to understand how a specific type of immune cell, called MAIT cells, is involved in hidradenitis suppurativa (HS), a painful chronic skin condition. Researchers will collect blood and skin samples from 45 adults with moderate-to-severe HS and compare them to peopl…

This study aims to better understand the real-life burden of hidradenitis suppurativa (HS), a painful and often misdiagnosed skin condition. It will observe 100 Canadian adults with HS to measure how the disease affects their work productivity, daily activities, pain levels, and …